Rebecca Robbins
Posts
U.S. Sues to Block Amgen’s $27.8 Billion Takeover of Horizon Therapeutics
The Federal Trade Commission said the deal would enable Amgen to “entrench” the monopoly positions of two Horizon drugs that lack competition.
U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs
In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea...
FDA Approves Biogen’s Drug for Rare Form of ALS
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness.
Sanofi Plans to Cut the Price of Insulin
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month.
Novo Nordisk Says It Will Slash the Price of Insulin
The company’s decision follows a similar move by its rival, Eli Lilly, this month.
A Drug Company Exploited a Safety Requirement to Make Money
With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
F.D.A. Allows Pharmacists to Prescribe Pfizer’s Covid Treatment Pills
Previously, only doctors, nurses or physician assistants were allowed to prescribe the treatment, known as Paxlovid.
W.T.O. Agrees to Limited Relaxing of Patent Protections on Covid Vaccines
The agreement is a limited measure that is likely to have little impact on global vaccine supply.
Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
The drug company will effectively give up on marketing Aduhelm, which comes with unproven benefit and serious safety risks.